Publication | Open Access
Aleglitazar, a new, potent, and balanced dual PPARα/γ agonist for the treatment of type II diabetes
103
Citations
9
References
2009
Year
Diabetes ManagementMedicineDiabetesPharmacological AgentPharmacotherapyDual Pparα/γ AgonistDiabetes MellitusPharmacologyType Ii DiabetesDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1